PMID- 25448925 OWN - NLM STAT- MEDLINE DCOM- 20150324 LR - 20220331 IS - 1528-0012 (Electronic) IS - 0016-5085 (Linking) VI - 148 IP - 2 DP - 2015 Feb TI - Efficacy of transoral fundoplication vs omeprazole for treatment of regurgitation in a randomized controlled trial. PG - 324-333.e5 LID - S0016-5085(14)01208-6 [pii] LID - 10.1053/j.gastro.2014.10.009 [doi] AB - BACKGROUND & AIMS: Transoral esophagogastric fundoplication (TF) can decrease or eliminate features of gastroesophageal reflux disease (GERD) in some patients whose symptoms persist despite proton pump inhibitor (PPI) therapy. We performed a prospective, sham-controlled trial to determine if TF reduced troublesome regurgitation to a greater extent than PPIs in patients with GERD. METHODS: We screened 696 patients with troublesome regurgitation despite daily PPI use with 3 validated GERD-specific symptom scales, on and off PPIs. Those with at least troublesome regurgitation (based on the Montreal definition) on PPIs underwent barium swallow, esophagogastroduodenoscopy, 48-hour esophageal pH monitoring (off PPIs), and high-resolution esophageal manometry analyses. Patients with GERD and hiatal hernias